SEC Form 4 · accession 0001213900-18-010829
ORAMED PHARMACEUTICALS INC. · ORMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aviad Friedman
Director
Period of report
Aug 9, 2018
Accepted (ET)
Aug 13, 2018 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001176309
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 9, 2018 | P | 500 | $4.82 | A | 10,191 | I | By wholly-owned corporation |
| Common Stock | Aug 9, 2018 | P | 2,000 | $4.98 | A | 12,191 | I | By wholly-owned corporation |
| Common Stock | holding | — | — | — | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.